CSR’s Mission and Function and What’s New in Peer Review Martha M. Faraday, Ph.D. Scientific Review Officer Division of AIDS, Behavioral & Population Sciences Risk Prevention & Health Behavior IRG Psychosocial Risk & Disease Prevention Study Section Date : April 22, 2009 National Institutes of Health U.S. Department of Health and Human Services
National Institute on Alcohol Abuse and Alcoholism National Institute of Arthritis and Musculoskeletal and Skin Diseases National Cancer Institute National Institute on Drug Abuse National Institute of Environmental Health Sciences National Institute on Aging National Institute of Child Health and Human Development National Institute on Deafness and Other Communication Disorders National Eye Institute National Human Genome Research Institute National Institute of Mental Health National Institute of Neurological Disorders and Stroke National Institute of General Medical Sciences National Institute of Nursing Research National Library of Medicine National Center for Complementary and Alternative Medicine National Institute of Allergy and Infectious Diseases Fogarty International Center National Center for Research Resources Clinical Center National Center on Minority Health and Health Disparities National Institute of Biomedical Imaging and Bioengineering Office of the Director Center for Information Technology National Heart, Lung, and Blood Institute National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health Center for Scientific Review
CSR Mission Statement To see that NIH grant applications receive fair, independent, expert, and timely reviews - free from inappropriate influences - so the Institutes and Centers within the NIH can fund the most promising research.
Scientific Review Process Dual Review System for Grant Applications Second Level of Review NIH Institute/Center Council First Level of Review : CSR/Institute Review Scientific Review Group (SRG) (Study Section)
Translational and Clinical Sciences Cardiovascular and Respiratory Sciences Surgical Sciences, Biomedical Imaging and Bioengineering Musculoskeletal, Oral And Skin Sciences Oncology 2 – Translational Clinical Vascular and Hematology Physiological and Pathological Sciences Endocrinology, Metabolism, Nutrition & Reproductive Sciences Immunology Infectious Diseases & Microbiology Digestive, Kidney & Urological Systems Neuroscience, Development and Aging Brain Disorders & Clinical Neuroscience Molecular, Cellular & Developmental Neuroscienc e Integrative, Functional & Cognitive Neuroscience Emerging Technologies & Training in Neuroscience Biology of Development & Aging Biobehavioral & Behavioral Processes Risk, Prevention& Health Behaviors Population Sciences & Epidemiology Healthcare Delivery & Methodologies AIDS & Related Research AIDS, Behavioral and Population Sciences Basic and Integrative Biological Sciences Biological Chemistry & Macromolecular Biophysics Bioengineering Sciences & Technologies Genes, Genomes & Genetics Oncology 1 – Basic Translational Cell Biology Interdisciplinary Molecular & Training CSR Review Divisions
Standing Study Sections when the subject matter of the application matches the referral guidelines for the study section
Special Emphasis Panels (SEPs) when the subject matter does not fit into any study section, or when assignment of an application to the most appropriate study section would create a conflict of interest. Also used for special mechanisms (e.g., fellowships, SBIRs, AREAs)
Assignment to CSR Review Groups Within an IRG, applications are assigned for review to
Reviewers should provide text for only those criteria that are applicable.
1. Significance 6. Resubmission 13. Overall Impact 2. Investigator(s) 7. Renewal 14. Budget and Period of Support 3. Innovation 8. Revision 15. Select Agents 4. Approach 9. Protection of Human Subjects 16. Applications from Foreign Organization 5. Environment 10. Inclusion of Women, Minorities, and Children 17. Resource Sharing Plan 11 Vertebrate Animals 18. Additional Comments to Applicant 12. Biohazards
Discussed applications will receive an overall score from each eligible (i.e., without conflicts of interest) panel member and these scores will be averaged to one decimal place, and multiplied by 10. The 81 possible priority scores will thus range from 10-90 .